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 Antibiotic Goals 
• Promote bacteria death 
• Prevent the emergence of resistance 
• Avoid toxicity 
  
Underdosing 
 Increase in Volume of distribution 
 Increase in clearance 
Dose of Antibiotics 
  How much? 
Antibiotic must not only attach to target but must occupy an 
adequate number of binding sites 
That depends on drug concentration within the organism and also on 
bacteria susceptibility – MIC 
Usually antibiotic concentration must be over 3-5 times MIC 
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Aminoglycosides 
Metronidazol 
Azithromycin 
Fluoroquinolones 
Beta-lactams 
Carbapenems 
Time (hours) 
Concentration 
Cmax 
T>MIC 
Area under the concentration curve 
MIC 
Patterns of Antimicrobial Activity 
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Time (hours) 
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Antimicrobial exposure 
Mainly dependent 
of VD 
Mainly dependent of 
the Clearance 
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Peak Concentration and Volume of 
Distribution 
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Beta-Lactam 
500 mg 
Fluoroquinolone 
500 mg 
Vd 15-20 liters 
Vd 80-200 liters 
Vd (L)=Dose (mg) 
            Conc (mg/L)  The apparent volume of distribution indicates into 
how large a volume the drug distributes if it were at the 
sa e concentration as that in plasma 
 
 Initial peak concentration is only dependent on dose 
and volume of distribution 
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Rate of elimination = Cl x C in plasma  
 (Amount / Unit of time)= (Volume / Unit of time) x Cin plasma  
   
  
Clearance 
Clearance is the volume of plasma completly cleared of the drug 
per unit of time by all routes - the liver, the kidney… 
Elimination of most drugs from the body after 
therapeutically relevant doses follows  
 first-order kinetics. 
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Clearance 
Elimination of most drugs from the body after 
therapeutically relevant doses follows  
 first-order kinetics. 
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Dose=100 mg, Vd=10 L, 
C0=Dose/Vd = 10 mg/L
 dC/dt = - kel . C  
First order PK 
Amount of drug that is 
eliminated depends of its 
initial concentration.  
According an increased 
Vd usually compensates 
for an increased Cl. 
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Volumes of compartments in 
relation to Vd 
Total body water  0.6 L/kg BW    
• Intracellular water 0.4 L/kg BW   
• Extracellular water 0.2 L/kg  BW 
• Plasma           0.04 L/kg BW  
 
Vd 0.05 L/kg the drug remains in the blood (heparine) 
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Volumes of compartments in 
relation to Vd 
Total body water  0.6 L/kg BW    
• Intracellular water 0.4 L/kg BW   
• Extracellular water 0.2 L/kg  BW 
• Plasma           0.04 L/kg BW  
 
Vd 0.05 L/kg the drug remains in the blood (heparine) 
Vd 0.1-0.3 L/kg distribution from blood into extracellular fluid (gentamicin). 
Vd  0.6 L/kg distribution from blood into intra and extracellular fluid (methotrexate) 
Vd >>0.6 L/kg distribution intracellularly and high binding in tissues (amiodarone)  
What about fat tissue? 
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Body Weight Calculations 
<25 Normal 
25-30 Overweight 
>30 Obese 
>35 Morbidly obese 
>55 Super-morbidly obese 
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Obesity and Pharmacokinetics 
Pharmacokinetic changes in obesity in general 
– Absorption 
• Little data exists on differences -> maybe delayed gastric 
emptying 
– Distribution 
• Lipophilic medications should be dosed on total body weight 
due to higher distribution volumes  
• Hydrophilic medications should be dosed on ideal body weight 
or adjusted body weight due to lower volumes of distribution  
 
 
Curr Opin Infect Dis 2012;25:634-49 
Clin Pharmacokinetic 2012;51:277-304 
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Pharmacokinetic changes in obesity in general 
– Absorption 
• Little data exists on differences -> maybe delayed gastric emptying 
– Distribution 
• Lipophilic medications should be dosed on total body weight due to higher distribution 
volumes  
• Hydrophilic medications should be dosed on ideal body weight or adjusted body weight due 
to lower volumes of distribution  
 
– Metabolism 
• CYP3A4 has lower drug clearance; CYP2E1 and most phase 2 enzyme systems 
have higher clearance; CYP1A2, CYP2C9, CYP2C19 and CYP2D6 trend towards 
higher clearance 
 
– Excretion 
• Obesity results in an increase in baseline renal clearance, but has 
a higher incidence of renal dysfunction from hypertension or diabetes 
Curr Opin Infect Dis 2012;25:634-49 
Clin Pharmacokinetic 2012;51:277-304 
Obesity and Pharmacokinetics 
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Loading Doses 
To achieve therapeutic concentrations rapidly loading doses 
are recommended 
Recommend giving high end of normal loading dose (or even higher 
dose) 
– Example: Vancomycin (normal patient Vd ~0.7 L/kg) 
• 100kg septic shock patient 
• Recommended loading dose for complicated infections in 
seriously ill patients is 25-30 mg/kg based on actual body 
weight 
 
– Am J Health-Syst Pharm 2009;66:82-98 
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Loading Doses 
To achieve therapeutic concentrations rapidly loading doses 
are recommended 
Recommend giving high end of normal loading dose (or even higher 
dose) 
– Example: Vancomycin (normal patient Vd ~0.7 L/kg) 
• 100kg septic shock patient 
 
 
Recommended loading dose for complicated infections in seriously ill 
patients is 25-30 mg/kg based on actual body weight 
 
– Am J Health-Syst Pharm 2009;66:82-98 
Hall. Am J Med. 2008; 121: 515–518 
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Longo. Pharmacoepidemiology and Drug Safety 2013; 22: 970–976 
Predictors of antibiotic failure 
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Serum drug concentrations obtained in 
obese and nonobese patients 
Hites M Antimicrob. Agents Chemother. 2013;57:708-715 
In obese patients without 
renal failure the probability 
of target attainment was 
lower 
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Hites M Antimicrob. Agents Chemother. 2013;57:708-715 
Volume of Distribution 
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Clearance 
In obese patients the 
total Vd is higher but the 
Vd/kg is lower  
Serum drug concentrations obtained in 
obese and nonobese patients 
Jo
ão
 G
.P
ereira 
Pharmacokinetics and total concentration of 
ertapenem versus time profile over 6 h 
according to weight 
Chen M Antimicrob. Agents Chemother. 2006;50:1222-1227 
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Vd (l) and Cl (l/1,73m2) 
Decrease AUC with 
increasing weight and Vd 
Vd increase with weight whilst Vd/kg decreases 
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Percent probability of attaining the 
target of 20% (A) or 40% (B) for 
fT>MIC with a single 1-gram dose of 
ertapenem at MICs of 0.25, 0.5, 1, 2, 
4, and 8 μg/ml in normal-weight, class 
I-II obese, and class III obese groups. 
Chen M Antimicrob. Agents Chemother. 2006;50:1222-1227 
Small difference but no dosage 
adjustment was recommended 
Pharmacokinetics and total concentration of 
ertapenem versus time profile over 6 h 
according to weight 
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Fat 
tissue 
Lipophilic drugs            +                 (TBW) 
Hydrophilic drugs             +  K  *           (ABW) 
K depends on water content and tissue affinity – usually 0,37-0,58 
Obesity and Volume of Distribution 
 
 
No fat distribution                                    (IBW) 
=TBW-IBW 
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Dosing Recommendations 
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MIC 
Time 
Cmax 
AUC 
T>MIC 
Vd 
Cl 
Healthy 
Gonçalves-Pereira. Crit Care 2011, 15:R206 
 Antibiotics Pharmacokinetics 
Vd 
Cl 
Time 
Cmax AUC 
MIC 
T>MIC 
Organ Failure 
Vd 
Cl 
MIC 
Time 
AUC 
T>MIC 
Cmax 
Sepsis 
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 Always use high loading doses – according to ABW or TBW 
 
 Adjust maintenance dose according to Pharmacodynamics and 
Clearance        (especially peak dependent drugs) 
• Steady state concentration most likely not affected 
 
Consider renal function and aumengted renal clearance  
• 65,1% of patients with normal creatinine 
 Udy, Crit Care Med 2014; 42:520–527 
 
 In unstable obese patients use therapeutic drug monitoring 
whenever possible 
• Alternative: population pharmacokinetics 
 
Dosing Recommendations 
 Obese Population 
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